Induced pluripotent stem (iPS) cells hold great promise for regenerative medicine. To overcome potential problems associated with transgene insertions, efforts have been directed over the past several years to generate transgene-free iPS cells by using nonviral-vector approaches. To date, however, cells generated through such procedures have had problems producing reproductively competent animals, suggesting that their quality needed further improvement. Here we report the use of optimized assemblies of reprogramming factors and selection markers incorporated into single plasmids as nonintegrating episomes to generate germline-competent iPS cells. In particular, the pMaster12 episome can produce transgene-free iPS cells that, when grown in 2i medium, recapitulate good mouse ES cells, in terms of their competency for generating germ-line chimeras.
Induced pluripotent stem (iPS) cells hold great promise for regenerative medicine. To overcome potential problems associated with transgene insertions, efforts have been directed over the past several years to generate transgene-free iPS cells by using nonviral-vector approaches. To date, however, cells generated through such procedures have had problems producing reproductively competent animals, suggesting that their quality needed further improvement. Here we report the use of optimized assemblies of reprogramming factors and selection markers incorporated into single plasmids as nonintegrating episomes to generate germline-competent iPS cells. In particular, the pMaster12 episome can produce transgene-free iPS cells that, when grown in 2i medium, recapitulate good mouse ES cells, in terms of their competency for generating germ-line chimeras.
A lthough induced pluripotent stem (iPS) cells hold enormous promise for cell-based therapies (1, 2) , their use in humans is still problematic because of their potential to also do harm to the patient. High among these risk factors is their potential to induce cancer. For example, use of viral vectors to randomly integrate genes into somatic cells used for human gene therapy trials has resulted in the induction of cancer in the recipient patients (3) . Also, random integration of the exogenous reprograming genes in iPS cells increases tumor formation, morbidity, and mortality in mice generated from these cells (4, 5) . Therefore, the safety and quality of iPS cells are of critical importance to their anticipated use for human cell-based therapies. To circumvent some of these safety issues, safer methods, especially nonviral methods, for the introduction of the reprogramming factors into somatic cells are being developed. These methods have included the use of plasmids (6, 7) , the piggyBac (PB) transposon (8, 9) , nonintegrating episomes (10) (11) (12) (13) , protein transduction (14, 15) , transfection of mRNA and microRNAs (16) (17) (18) , and small molecule inhibitors (19) . Although these approaches have yielded transgene-free iPS cells, the competency of the resulting iPS cells to contribute to a functional germ line has not been adequately demonstrated.
Results
Of the many procedures suggested to date for generating transgenefree iPS cells, episome-mediated protocols have appeared promising. Previous reports on the use of episomes as the carrier of reprogramming factors have used a combination of three separate episomal vectors (10, 11) . As a consequence, hundreds of copies of the episomal vectors were present in the resultant iPS cells. Although episomal vectors can be lost gradually over time, the high-passage numbers (>20) needed to derive episome-free cells would likely result in the accumulation of deleterious genomic alterations that could compromise these cells (11) . Furthermore, the germ-line competency of iPS cells generated by this method had not yet been evaluated. To overcome the need for multiple episomes, we linked the four human genes POU class 5 homeobox 1 (POU5F1/OCT4), Kruppel-like factor 4 (KLF4), sex determining region Y (SRY)-box 2 (SOX2), and v-myc avian myelocytomatosis viral oncogene homolog (cMYC) (OKSM) by 2A sequences and added genes Nanog homeobox (NANOG) and lin-28 homolog (LIN28), neo, and HSVtk into pMaster1 (Fig.  1A) . We also constructed the pMaster3 episome vector that contains, in addition to the genes present in pMaster1, the NR5A2 gene (nuclear receptor subfamily 5, group A, member 2) that was previously shown to facilitate reprogramming (20) . Finally, to produce pMaster12, the microRNA 302/367 gene cluster, which also was previously reported to participate in the reprogramming of mouse and human fibroblasts into iPS cells (16) , was added to pMaster3.
Introduction of the pMaster1 plasmid into Oct4-GFP mouse embryonic fibroblasts (MEFs) (21) generated iPS cells at a reasonable efficiency of ∼0.01-0.02%. The iPS cell clones could be readily expanded and showed GFP expression, indicating activation of the endogenous Oct4 gene (Fig. 1B) . We seeded primary iPS cells (passage 0) in 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU)-containing medium to select for cells that have lost the tk-bearing episome. On average, 0.01% of cells survived FIAU selection. Approximately 25% of the clones picked following FIAU selection were sensitive to G418, implying they had also lost neo. PCR confirmed the absence of neo and tk. Surprisingly, however, PCR analysis with 18 primer pairs covering the entire pMaster1 episome demonstrated persistence of the OKSM genes (Fig. S1A) . The partial loss of transgenes from the episome suggested incomplete reprogramming using the pMaster1 episome for generation of iPS cells, thereby necessitating retention of the OKSM genes.
Next, pMaster3 and pMaster12 were evaluated. Slightly fewer colonies appeared on the primary culture plates following transfection of pMaster3, but they displayed more compact mouse ES-cell-like morphology ( Fig. 1 C and D) . With pMaster12, 10-fold more colonies appeared on the primary culture plates Significance Using a single, nonintegrating episome, containing an optimized assembly of reprogramming factors and positive/negative selection markers, we generated germ-line-competent induced pluripotent stem (iPS) cells. To ensure that the iPS cells were transgene-free (i.e., were independent of exogenous reprogramming factors to achieve and maintain their pluripotent ground state) required the inclusion on the episome more that the classical four (POU5F1/OCT4, KLF4, SOX2, and cMYC) reprogramming factors. Also critical for the transgene-free iPS cells exhibiting competency for germ-line transmission was the requirement for growth in 2i medium. Data deposition: The reprogramming vectors generated in this study have been deposited in the Addgene database (www.addgene.org) (Addgene nos. 58525, 58526, and 58527). 1 To whom correspondence should be addressed. Email: mario.capecchi@genetics.utah. (efficiency, 0.20 ± 0.03%). These primary pMaster12-derived iPS cells (nine lines tested) at passage 1 contained 4.3 ± 3.0 copies per cell of the pMaster12 episome as determined by real-time PCR, much fewer than previously reported ∼200 copies (11). When pMaster3-or 12-derived clones were subjected to FIAU selection, ∼25% of the primary clones produced G418-sensitive secondary clones. PCR analysis of pMaster3-derived clones showed persistence of the NR5A2 gene in some, but not all, of these clones (e.g., iPS466F38; Fig. S1B ). PCR analysis of pMaster12-derived secondary clones with 21 primer pairs that covered the episome validated the complete removal of all of the episomal sequences in the majority (23 of 30) of the G418-sensitive clones ( Fig. 2A and Fig. S1C ).
Because our primary pMaster12-derived iPS cells at passage 1 contained only a few copies of the episome, we examined the efficiency of deriving transgene-free clones by simple passaging, without using negative selection. Among 12 primary clones tested, 2 became completely transgene-free at passage 7 as a whole plate without subcloning.
Immunostaining of pMaster3-and pMaster12-derived transgene-free iPS cell lines, such as iPSZX11-18-2, showed homogeneous expression of endogenous pluripotency markers (Fig.  2B ). pMaster vector-derived iPS cell lines demonstrated normal karyotypes, with the exception of iPS466F46 ( Fig. 2C and Fig.  S2 ). Some were maintained for >35 passages without detectable changes in karyotype, morphology, or growth characteristics.
To test the ability of pMaster-derived iPS cell lines to generate germ-line chimeras, we performed blastocyst and eight-cell morula injections. Five lines grown in conventional ES cell medium generated several low-percent coat color chimeras and one high-percent coat color chimera (Table S1) . Surprisingly, none of these chimeras showed germ-line transmission after extensive breeding. Often in the field it is taken for granted that if iPS cells can contribute to chimera formation, they will also produce germline offspring. Our separate results in PB transposon-derived iPS cells and current results indicate the contrary. Therefore, it is troubling that iPS cell publications often only present chimeric results without demonstrating germ-line competency, potentially misrepresenting the quality of transgene-free iPS cell that have been obtained.
The 2i medium, which contains small molecule inhibitors of the Mek/Erk and GSK3b pathways, has been shown to promote cells to a more pluripotent state (22) (23) (24) . We tested the germ-line competency of pMaster1-derived (iPS322-38s, iPS322-40t, iPS344F28, and iPS344F30), pMaster3-derived (iPS466F38 and iPS466F46), and pMaster12-derived (iPSZX11-18-1 and iPSSZX11-18-2) cell lines grown in 2i medium. All eight lines produced high-percentage chimeras, and seven generated germline chimeras (Table S2 and Fig. S3 ). For example, iPSZX11-18-2 cells produced five females that were >50% chimeric by coat color (Fig. 3 and Table S2 ). Matings to wild-type males transmitted the Oct4-GFP allele to >33% of progeny (because Oct4-GFP is a heterozygous allele, the maximum possible transmission frequency is 50%). Extensive PCR analysis of offspring confirmed the absence of exogenous reprogramming genes (Fig.  S1C) . These results illustrated that transgene-free iPS cells can exhibit germ-line competencies comparable to excellent commonly used mouse ES cell lines (e.g., R1 and G4) (25, 26) . It has been demonstrated that the use of serum-free 2i medium is generally better than using one of the molecules or complementation of serum medium with 1i or 2i (22) . Both Mek and Gsk3b inhibition were required to have more robust effects. The 2i medium significantly improved the attainment of germline competency for pMaster-derived iPS cells. To explore the mechanism of how 2i medium improves iPS cell quality, we performed genome-wide microarray analysis of seven iPS cell lines (pMaster1: iPS322-38s, iPS322-40t, iPS322-45w, iPS344F28, and iPS344F30; pMaster3: iPS466F38 and iPS466F46) and two ES cell lines (R1 and G4), cultured in defined 2i medium or serum containing medium. All of the pMaster1 cell lines still retained the six transgenes (OKSM, NANOG, and LIN28). The pMaster3 line iPS466F46 was transgene-free, and iPS466F38 retained NR5A2, but not the other transgenes. All of the lines analyzed, except iPS466F46, exhibited normal karyotypes. Six of those pMaster1 or pMaster3 cells (Table S2) (Fig. 4A) . Pair-wise comparison analysis revealed that 687 genes were expressed more than twofold higher in defined 2i medium, whereas 1,295 genes were expressed more than twofold higher in serum-containing medium (Fig. 4B ). We found typical marker genes related to the differentiation of the three germ layers were activated in serumcontaining medium compared with 2i medium (Fig. 4C) . To functionally annotate differentially expressed genes for iPS cells grown in 2i vs. serum medium, we analyzed these genes through Gene Ontology (GO) terms and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Genes higher in 2i medium (Fig. 4 D-G) were highly enriched for terms of the innate immune response, which may lower the obstacles to reprogramming (27) . It was also apparent that 2i medium greatly inhibited expression of genes related to cell differentiation and tissue and organ development, suggesting more effective maintenance of the iPS cells in an undifferentiated "ground state" (Fig. 4 C-F) . Marks et al. have compared the gene expression profiles of mouse ES cell lines grown on defined 2i and ES serum-containing medium (23). Our results of comparing the iPS cell transcriptomes grown under very similar culture conditions were in very good agreement with their study, in terms of which genes were expressed or repressed. The results of inhibition of differentiation genes and enhanced expression of genes of the innate immune response system observed from growth in 2i medium relative to serum-containing medium may account for the marked improvement of iPS cell quality, with respect to germ-line competence. Consistent with previous observations that 2i medium induced reactivation of the X chromosome (22-24), we also found that Xist expression was significantly reduced in the 2i medium group.
Although all three pMaster vector-derived clones had germline potential, there were important differences among them. It has not been possible to obtain transgene-free iPS cell clones using the pMaster1 vector, and all FIAU-selected pMaster1 clones examined retained the six reprogramming genes (OKSM+NANOG+LIN28). pMaster3 clones tended to retain as least one reprogramming gene. However, the majority of pMaster12-derived clones were transgene-free. To further explore underlying differences among iPS cell lines derived by these three vectors, we compared the transcriptome of pMaster iPS cell clones grown in 2i medium derived from each vector with that of the G4 ES cells also grown in 2i medium. Differentially expressed genes were again functionally annotated through GO terms and KEGG pathways (Figs. S4 and S5 ). From pMaster1, pMaster3, and pMaster12, up-regulated genes in their derived iPS cells were enriched for fewer and fewer GO and KEGG Oct4-GFP Phase Nanog Fig. 2 . In vitro characterization of pMaster12-derived transgene-free iPS cells. (A) PCR confirmation of removal of pMaster12 vector in the iPSZX11-18-2 cell line. In clone iPSZX11-18-2, pMaster12 sequences were not detected by PCR using 21 primer pairs (Fig. S1 and Table S3 ) covering the entire vector, whereas the endogenous Oct4-GFP transgene could be detected. Purified pMaster12 DNA was used as control. (B) Immunostaining of transgene-free iPSZX11-18-2 cells demonstrated that the endogenous pluripotency genes (e.g., Oct4, Sox2, Nanog, and Ssea1) are active after the loss of pMaster12 vector. (C) iPSZX11-18-2 cells have a normal female karyotype.
terms associated with cell differentiation and organ development (Fig. S5) . Compared with pMaster1, down-regulated genes in pMaster3 and pMaster12 iPS cells were enriched for fewer GO and KEGG terms associated with immune function and metabolic processes (Fig. S5) . These results were consistent with pMaster12 iPS cells being more similar to the ES cells with respect to their gene expression profiles. Interestingly, from pMaster1 to pMaster3, the addition of NR5A2 gene in the pMaster3 vector allowed, to our knowledge, for the first time in our hands, complete removal of transgenes. The NR5A2 gene has previously been shown to improve pluripotency (20) . To further dissect the potential role of the NR5A2 gene, we grouped ES cells with pMaster3-derived iPS cells and compared this group with the pMaster1-derived cells. Approximately 70 genes were observed to be differentially (more than twofold) expressed (Fig. S6) . These differentially expressed genes may be used to further increase the reprogramming efficiency and iPS cell quality.
Discussion
We have described herein a single plasmid/episome system for mediating reprogramming of somatic cells to pluripotent iPS cells. These vectors are user-friendly by design. It appears from this work that inclusion of more reprogramming factors than the classical four greatly improves the probability of the reprogrammed cell gaining independence from the exogenously added factors to maintain pluripotency. Also, growth in 2i medium, compared with normal ES cell medium, greatly improves the ability of the newly generated iPS cell to contribute to germline formation.
The value of ES cells has been exemplified by the success of the knockout mouse technology (28) . After decades of efforts, however, authentic ES cells have only been isolated in one other species, the rat (29, 30) . Use of our pMaster vectors may prove useful for production of germ-line-competent transgene-free iPS cells to use as surrogates for ES cells in those species for which authentic ES cell lines have yet to be developed (31) . The validation of the reported technologies to generate transgene-free iPS cells from MEF and ultimately production of healthy germline chimeras from these iPS cell lines is a critical and singular contribution. Indeed, we showed that cell lines generated by the PB vector system failed this most stringent test, even after passing all of the typical in vitro tests for transgene-free iPS cells. The ability to generate transgene-free iPS cells with attributes common to mouse ES cells should bring us closer to the use of such iPS cell lines for human cell-based therapy.
Materials and Methods
Plasmid Construction. To construct the pMaster series vectors, we used the EF1a promoter-driven OKSM expression cassette and the CAG promoter driven positive/negative selection cassette. NANOG and LIN28 cDNAs were fused by F2A sequence by PCR. All reprogramming genes used were of human origin. Components were assembled onto the pCEP4 episomal mammalian expression vector backbone that contains the Epstein-Barr virus replication origin (oriP) and nuclear antigen (encoded by the EBNA1 gene). All reprogramming vectors generated in this study will be deposited in Addgene.org for wide distribution.
Cell Culture and Media. MEFs from strain 129Sv were isolated from pooled embryonic day 14 (E14) embryos. To isolate MEFs from the Oct4-GFP transgenic mouse line [Jax Mice strain name: B6; CBA-Tg(Pou5f1-EGFP) 2Mnn/J; stock no. 004654], we crossed a homozygous Oct4-GFP male to 129Sv females and isolated E14 MEFs from pooled F1 heterozygous embryos.
ES medium (serum medium) was prepared by supplementing DMEM with 15% (vol/vol) FBS, 500 units/mL Lif, and 0.1 mM 2-mercaptoethanol.
The 2i medium was made by mixing 500 mL of DMEM/F12 medium (Invitrogen; 10565-042), 500 mL of Neurobasal medium (Invitrogen; 21103-049), 5 mL of N2 supplement (Invitrogen; 17502-048), 10 mL of B27 supplement (Invitrogen; 17504-044), 5 mL of 100× Pen-Strep (Invitrogen; 15070-063), 2-mercaptoethanol (final concentration of 0.1 mM), Lif (Millipore; ESG1107; final concentration of 1,000 units/mL), PD0325901 (Selleck; final concentration of 1 μM), and CHIR99021 (Selleck; final concentration of 3 μM).
Reprogramming MEFs with pMaster Vectors. For each electroporation experiment, 2 × 10 6 MEFs were used, and 3 μg of pMaster DNA was transfected by using the Lonza Amaxa Nucleofector, program A-024. Electroporated cells were transferred into prewarmed ES medium (serum medium) and plated onto 10-cm culture plates containing irradiated feeders. At 20-24 h after transfection, we applied G418 selection at a concentration of 350 μg/mL. Transgene-free iPS cell line iPSZX11-18-2 was generated with pMaster12, and blastocyst injection produced 11 female chimeras (one example is shown in Left Upper), two of which have generated iPS-derived progeny at high frequencies (44% by coat color, 33% by Oct4-GFP). (B) The iPS466F38 cell line was generated with pMaster3 from 129Sv/BL6 Oct4-GFP MEFs. Blastocyst injection produced 10 male chimeras (one example is shown in Left Upper). Nine chimeras were mated, and seven produced iPS-derived progeny at very high frequencies (45%). Because these iPS cells only have one copy of the agouti gene and one copy of the Oct4-GFP gene, the maximum germ-line transmission frequency that can be detected by either marker is 50%. iPS322-38s, iPS322-40t, iPS322-45w, iPS344F28, and iPS344F30; pMaster3: iPS466F38 and iPS466F46), two ES cell lines (R1 and G4), and two MEF lines (wt 129Sv and 129Sv/BL6 F1 Oct4-GFP), cultured in 2i or serum medium. All of the pMaster1 cell lines still retain the six transgenes (OKSM, NANOG, and LIN28). The pMaster3 lines iPS466F38 and iPS466F46 retain NR5A2 and no transgene, respectively. All of the lines analyzed except iPS466F46 have normal karyotype. Six of those pMaster1 or pMaster3 cells (Table S2 ) grown in 2i medium and used for blastocyst injection gave germline transmission. All of the iPS and ES cell lines are male lines. Each iPS or ES cell line was grown in ES cell medium and 2i medium, for more than three passages before use. Hierarchical clustering was performed by using 6,144 significantly different genes. (B) Differentially expressed genes in 2i vs. serum medium (more than twofold; P < 0.05). Pair-wise comparison revealed that 687 genes expressed more than twofold higher in 2i medium, whereas 1,295 genes expressed more than twofold higher in serum medium. (C) Expression of genes associated with development of three germ layers. Most of these typical marker genes related to various germ layers are activated in serum medium compared with 2i medium. (D) Up-regulated genes in 2i medium are enriched for GO terms associated with immune response and metabolic processes. (E) Up-regulated genes in serum medium are enriched for GO terms associated with cell differentiation and tissue and organ development. (F) Up-regulated genes in 2i medium are enriched for KEGG terms linked to glycosphingolipid biosynthesis, metabolism of xenobiotics by cytochrome P450, complement and coagulation cascades, and glutathione metabolism. (G) Up-regulated genes in serum medium are enriched for KEGG terms linked to the VEGF signaling pathway, axon guidance, hematopoietic cell lineage, etc.
Real-Time PCR. To quantify copy number of the pMaster12 plasmid in iPS cells, we performed real-time PCR with Roche LightCycler 480. To generate a standard curve, we mixed pMaster12 plasmid with MEF genomic DNA, at 1, 2, 4, 8, 16, and 32 copies per cell as standards, according to the following formula: pMaster12 (ng)/MEF genomic DNA (ng) = pMaster12 size (27,879 bp)/mouse genome size (2.726 × 10 9 bp). ΔCt = Ct for EBNA − Ct for Fabp2 gene, the endogenous gene control. ΔCt values were plotted against the number of cycles on a logarithmic scale to obtain the standard curve. EBNA primers used were as follows: EBNA-F (ATC AGG GCC AAG ACA TAG AGA TG) and EBNA-R (GCC AAT GCA ACT TGG ACG TT), and the product size was 60 bp. Fabp2 primers used were as follows: Fabp2-F (TGT TCA GAG CCA GGA AAT CCA TA) and Fabp2-R (CAT AGG TGT CTC TTT CTT TGG TGT GT), and the product size was 110 bp. The copy number of EBNA in each sample was estimated based on the ΔCt value.
Microarray Analysis. Miroarray analysis was performed by using the Agilent Mouse Gene Expression Microarray. Total RNA was prepared by using the Qiagen RNeasy kit. The Agilent One-Color Quick Amp Labeling Kit was used to generate fluorescently labeled cRNA for one-color microarray hybridizations. Microarray hybridizations were performed by using Agilent SureHyb Hybridization chambers. Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner. The normalized dataset was loaded into GeneSifter (Geospiza) for analysis.
Karyotyping. iPS cells were treated with Colcemid (0.1 μg/mL; Gibco; catalog no. 15212-012) for 20-30 min. Metaphase chromosomes were prepared by using a standard procedure. Chromosomes were analyzed by using a standard Giemsa-trypsin-Wrights banding method with help from ChihLin Hsieh (University of Southern California, Los Angeles).
Immunostaining. Cells were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature, and standard procedures were used for immunostaining with the following antibodies: polyclonal rabbit anti-Sox2 (Novus; NB110-37235), mouse IgM anti-SSEA1 (DSHB; MC-480), polyclonal rabbit antiNanog (Abcam; ab80892), and mouse IgG2b anti-Oct4 (Santa Cruz; sc-5279). After staining, cells were washed with PBS, and nuclei were counterstained with DAPI.
For chimera production by morula aggregation and blastocyst injection, we followed published procedures (32) . Laser-assisted injection of eight-cellstage embryos was performed according to a published procedure (33) . Recipient embryos for morula aggregation were from the CD1 mouse line. Recipient embryos for eight-cell or blastocyst injection were from the C57/ BL6 mouse line.
